glp-1 going away New research is taking a closer look at what can happen a year or more after people stop taking medications 3 Takeaways from the Landmark
Description
These medications mimic the action of the hormone GLP-1 (glucagon-like peptide-1), which helps manage blood sugar levels by stimulating insulin release, reducing glucagon secretion, and slowing gastric emptying
Endocrinology 139 , 41084114 (1998)

APTF-2 directly regulates glp-1 expression C
Save more money by taking advantage of the discounts at resbiotic.com
Additionally, individuals with NAFLD exhibit an impaired incretin effect independent of diabetes, displaying fasting hyperglucagonemia (8) and increased hepatic gluconeogenesis (9)

Kumarathurai P, Anholm C, Larsen BS, Olsen RH, Madsbad S, Kristiansen O, et al